Sensei Biotherapeutics Stock Cash Flow From Operations
| SNSE Stock | USD 8.55 0.45 5.00% |
Fundamental analysis of Sensei Biotherapeutics allows traders to better anticipate movements in Sensei Biotherapeutics' stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Sensei Biotherapeutics Company Cash Flow From Operations Analysis
Sensei Biotherapeutics' Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Sensei Biotherapeutics Cash Flow From Operations | (24.67 M) |
Most of Sensei Biotherapeutics' fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sensei Biotherapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, Sensei Biotherapeutics has (24.67 Million) in Cash Flow From Operations. This is 104.68% lower than that of the Biotechnology sector and 139.46% lower than that of the Health Care industry. The cash flow from operations for all United States stocks is 102.54% higher than that of the company.
Sensei Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sensei Biotherapeutics' direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sensei Biotherapeutics could also be used in its relative valuation, which is a method of valuing Sensei Biotherapeutics by comparing valuation metrics of similar companies.Sensei Biotherapeutics is currently under evaluation in cash flow from operations category among its peers.
Sensei Fundamentals
| Return On Equity | -0.7 | ||||
| Return On Asset | -0.37 | ||||
| Current Valuation | (11.67 M) | ||||
| Shares Outstanding | 1.26 M | ||||
| Shares Owned By Insiders | 32.57 % | ||||
| Shares Owned By Institutions | 4.04 % | ||||
| Number Of Shares Shorted | 928 | ||||
| Price To Book | 0.47 X | ||||
| EBITDA | (29.52 M) | ||||
| Net Income | (30.16 M) | ||||
| Cash And Equivalents | 123.71 M | ||||
| Cash Per Share | 4.03 X | ||||
| Total Debt | 3.85 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 23.46 X | ||||
| Book Value Per Share | 18.24 X | ||||
| Cash Flow From Operations | (24.67 M) | ||||
| Short Ratio | 0.03 X | ||||
| Earnings Per Share | (20.05) X | ||||
| Target Price | 32.5 | ||||
| Number Of Employees | 14 | ||||
| Beta | 0.31 | ||||
| Market Capitalization | 11.35 M | ||||
| Total Asset | 45.36 M | ||||
| Retained Earnings | (262.05 M) | ||||
| Working Capital | 36.48 M | ||||
| Net Asset | 45.36 M |
About Sensei Biotherapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sensei Biotherapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sensei Biotherapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sensei Biotherapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| PRNEX | T Rowe Price | |
| RPBAX | T Rowe Price | |
| PRDGX | T Rowe Price |
Check out Sensei Biotherapeutics Piotroski F Score and Sensei Biotherapeutics Altman Z Score analysis. For information on how to trade Sensei Stock refer to our How to Trade Sensei Stock guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sensei Biotherapeutics. If investors know Sensei will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sensei Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Sensei Biotherapeutics is measured differently than its book value, which is the value of Sensei that is recorded on the company's balance sheet. Investors also form their own opinion of Sensei Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sensei Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sensei Biotherapeutics' market value can be influenced by many factors that don't directly affect Sensei Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sensei Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sensei Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sensei Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.